Navigation Links
Fines Paid By Speeding Motorists Used in Funding Spinal Cord Injury Research

The New York State Department of Health is using fines paid by speeding motorist to fund research on spinal cord injury, whose number-one cause nationwide is motor vehicle// accidents. The Spinal Cord Injury Research Program created in 1998 uses these fines to fund research, and three research projects at the University of Rochester Medical Center are among the programs funded this year through this program. The grants are going to Roman Giger, Ph.D.; Maiken Nedergaard, M.D., Ph.D.; and Mark Noble, Ph.D.

Giger, associate professor in the Department of Biomedical Genetics and a scientist in the Center for Aging and Developmental Biology, will use a two-year, $300,000 grant to work closely with Shey Shing Sheu, Ph.D., professor of Pharmacology and Physiology, in an effort to identify molecules that stop nerves from growing back once they've been severed. Giger is an expert on how axon guidance molecules act as a sort of traffic cop in the central nervous system, determining the paths along which nerve cells grow to link up with each other to form vast networks. He has identified molecules that likely play a role in preventing the spinal cord from growing back after an injury. He'll work closely with Sheu, who is an expert at imaging calcium, an important communication tool cells use to do many things, including stopping neurons from growing. The team will use Sheu's system to learn more about such signals with the ultimate hope of persuading nerve cells in the spine to grow again.

Nedergaard, together with colleagues at New York Medical College, will use a four-year, $1.2 million grant to study the role of star-shaped cells known as astrocytes in spinal cord injury. Traditionally such research focuses on regeneration of neurons, the nerve cells that send electrical signals to one another. But Nedergaard, a professor in the Department of Neurosurgery and a researcher in the Center for Aging and Developmental Biology, has discovered that astr ocytes are very important in spinal cord injury as well as epilepsy, Alzheimer's disease, and migraine headaches. With a previous $1.25 million grant through the same program, she has found that soon after a spinal cord injury, astrocytes release high levels of a substance known as ATP that continues to kill neurons for hours after the injury. The new grant enables her team to continue its work exploring ways to lessen the damage from a spinal cord injury by targeting astrocytes.

Noble, a professor in the Department of Biomedical Genetics, is working together with Giger to focus on another aspect of spinal cord injury. In addition to the severing of nerves that is at the core of such an injury, the nerves sustain other damage, including the loss of the myelin covering that enables the nerves to send crisp electrical signals. Noble and Giger will use a two-year, $227,000 grant to try to identify the molecules in the central nervous system that prevent the remyelination of nerves that have been damaged. Noble is an internationally recognized expert in the biology of the specialized cells called oligodendrocytes that provide myelin for nerve cells. He and Giger will explore the complex molecular environment around the site of a spinal cord injury in an effort to find out what stops those cells from fixing damaged nerves in the spine.

In addition to his own research, Noble helps to manage spinal cord research throughout the state through his role as co-director of the New York State Center of Research Excellence in Spinal Cord Injury. The five-year, $15 million effort is funding a consortium of 18 top laboratories in a variety of approaches to ease the impact of spinal cord injury. In Rochester the program funds Noble, Giger, Margot-Mayer Proschel, Ph.D., and Peter Shrager, Ph.D.
'"/>




Related medicine news :

1. Copeman Healthcare May Face Government Fines
2. Court Fines Newspaper for Revealing AIDS Orphans Identity
3. American Red Cross Face Fines After Blood Safety Lapses
4. JCU Gets A$ 3 million Government Funding
5. China to double HIV Prevention Funding to $185M In 2006, 2007
6. Breast Cancer Funding To Be Extended By Another $30 Million: Pharmac
7. Increased Funding For AIDS/HIV Program In Africa
8. AIDS Funding Grants Dependant on Tracking Patients Names Efficiently
9. WHO: Lives At Risk In Sudan As Diseases Soar, Call for Funding
10. More Funding Needed For Stem Cell Research in India
11. Results of Clinical Trials Vary According to Source of Funding
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/3/2016)... Monica, CA (PRWEB) , ... May 03, 2016 , ... ... the highest quality medical providers to build the leading network of doctors and therapists ... Eric Nepomnaschy, D.C., founder of the distinguished Bay Chiropractic and Rehabilitation in ...
(Date:5/3/2016)... ... May 03, 2016 , ... SELEX (systematic evolution ... from a random library of sequences depending on their attraction for a target ... SELEX selection is commonly performed using filters, panning, or affinity chromatography separations. However, ...
(Date:5/3/2016)... FL (PRWEB) , ... May 03, 2016 , ... ... leading innovative specialty pharmacies, will be represented at the 2016 Asembia Specialty ... Vegas. The Asembia Summit is the largest U.S. health care conference for the ...
(Date:5/3/2016)... ... May 03, 2016 , ... Boston Children’s Hospital today announced its ... situations or practice tricky or rare procedures in an environment that looks and feels ... is also available to inventors and “hackers” to develop and test new devices or ...
(Date:5/3/2016)... ... May 03, 2016 , ... ... announces Benefits Alliance Insurance Services as the latest addition to its elite stable ... comprised of Partners Wayne Blasman, David Styles, and Paul Vincent. The Firm is ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... April 29, 2016  In the next ten ... shift from systems dependent on CRTs monitors to those ... modality CRT Medical monitors and will automatically sync ... host of foreseeable benefits to this technological advancement, ... modalities have to be replaced in order to ...
(Date:4/29/2016)... 29, 2016 Glycotope GmbH, a ... announces the appointment of Dr. Alfredo Zurlo ... an oncologist with many years clinical experience and a ... His last role was at Mologen AG where he ... Board. Previously Dr. Zurlo held various positions at F ...
(Date:4/28/2016)... April 28, 2016 Research and ... Plastic Surgery Products Market 2016-2020" report to their ... , The global plastic surgery products market ... during the period 2016-2020. , ,The growing adoption of ... the growth of the market. Lasers are used to ...
Breaking Medicine Technology: